Business Daily Media

Men's Weekly

.

Merck Announces Emerging Biotech Grant Program Winners

  • Award recipients to receive in-kind technologies and services to accelerate therapeutics to market
  • Merck experts to provide consultation and training in qualification, risk assessment, and process optimization
  • Program extended this year to Australia, New Zealand, Taiwan, South Korea

SINGAPORE - Media OutReach Newswire - 1 November 2024 - Merck, a leading science and technology company, today announced the winners of its Emerging Biotech (EB) Grant Program in Asia Pacific.

The Award is designed to support biotech startups with resources to enable emerging companies to discover, develop, optimize, and commercialize therapeutics faster and more efficiently.

Merck Emerging Biotech Award Recipients for Taiwan receiving their awards at the award ceremony.
Merck Emerging Biotech Award Recipients for Taiwan receiving their awards at the award ceremony.
Merck Emerging Biotech Award Recipients for Australia receiving their awards at the award ceremony.
Merck Emerging Biotech Award Recipients for Australia receiving their awards at the award ceremony.



"Merck is committed to supporting exceptional biotech companies to both kickstart and streamline their journey from discovery to manufacturing with our grant program," said Chua Keng Hock, Senior Vice President, Process Solutions Asia Pacific, Life Science business of Merck. "We recognize the complexities involved in delivering next-generation therapies to the market. Merck's EB Grant is designed to expedite the development of treatments that address critical unmet medical needs."

The award recipients are:

Country
Grand Prize Winner
Finalist Prize Winners
Special Mention
Australia & New Zealand
Southern RNA for enabling the manufacturing of mRNA for personalized medicines
Institute for Drug Technology for enabling the manufacturing of antibody-drug conjugates.

Psaio for developing bispecific antibodies targeting prostate-specific antigen to treat prostate cancer.
Kimer Med for developing

a family of broad-spectrum antiviral biologics to treat infectious diseases, and for pandemic protection.
Taiwan
HanchorBio for developing clinical-stage and next-generation immuno-oncology therapies through innovation in cutting-edge designer biologics with novel, multi-functional modalities.
Pell Biomed Technology for developing more efficient and cost-effective gene-modified cell therapies.

Glyconex for glycan-directed cancer therapies including antibody-drug conjugates to treat a range of solid tumors such as gastrointestinal cancers.
Shine-On BioMedical for developing targeted exosomes as a platform for drug delivery as well as tri-specific antibody for cancer treatment.

Merck experts selected the winning submissions based on the scientific and societal merit of the therapy in development and process challenges and expertise gaps that may impact ongoing development. In-kind technologies and services from Merck will be awarded to the winners in Australia & New Zealand and Taiwan to help solve these challenges.

Merck first started the EB grant program in 2014 in the United States and has expanded its reach to include Europe, China, South Korea and Taiwan in recent years. In 2024, the EB Grant was extended to Australia & New Zealand and is open to Taiwan and South Korea (the winners for South Korea were announced in July 2024). To-date, Merck's EB Grant program has awarded technologies and consultation to over 40 biotechnology companies around the world, supporting their efforts to improve patient outcomes for various diseases such as cancer, brain tumors, osteoarthritis, and cardiovascular disorders.

https://www.sigmaaldrich.com/SG/en/applications/pharmaceutical-and-biopharmaceutical-manufacturing/biotech-resource-hub/startup-programs#our-grant-programs

Other Merck grants at group level:
https://www.merckgroup.com/en/research/open-innovation.html

Hashtag: #Merck

The issuer is solely responsible for the content of this announcement.

About Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to to register online, change your selection or discontinue this service.

News from Asia

Vantage Data Centers Secures $1.6B Investment in APAC Platform from GIC and ADIA

Investment to support accelerated expansion in APAC, including acquisition of hyperscale data center campus in Johor, Malaysia, strengthening Vantage’s position as a market leader in Asia Pacific D...

AUX Commences Trading on Hong Kong Stock Exchange, Launching New Chapter in Global Growth

HONG KONG SAR - Media OutReach Newswire - 10 September 2025 - AUX Electric Co., Ltd. (Stock Code: 2580.HK), the core air conditioning business of AUX Group, listed on the Hong Kong Stock Exchange ...

BeOne Medicines Honored with the Global Oncology Innovation Leadership Award at BIOHK 2025, Supporting "1+" to Accelerate the Delivery of Innovative Cancer Therapies

HONG KONG SAR - Media OutReach Newswire - 11 September 2025 - BeOne Medicines (BeOne)(NASDAQ: ONC; HKEX: 06160; SSE: 688235), was honored today at BIOHK 2025, the Hong Kong International Biotechno...

Gree Showcases Photovoltaic DC Air Conditioning System at Gree Summit Partner, Positioning Singapore as Green Innovation Hub

SINGAPORE - Media OutReach Newswire - 11 September 2025 - Singapore has long been recognized as a pivotal hub in Gree's Southeast Asia growth strategy. With its advanced infrastructure, strong sus...

TIYA Conference 2025: Over 150 Youth Leaders from 15 Countries Gathered to Advance United Nations’ SDGs

Three-day conference in Singapore empowers young changemakers through mentorship and international collaborationSINGAPORE - Media OutReach Newswire - 11 September 2025 - Tzu-Chi Foundation (Singap...

Finex Collaborates with Sharing Happiness to Honor Indonesian Veterans

JAKARTA, INDONESIA - Media OutReach Newswire - 11 September 2025 - Finex, an acclaimed Indonesian broker, and Sharing Happiness, a charity organization, partnered to honor the members of the Indo...

Momcozy Honored at Kind+Jugend 2025 for Innovation in Maternal Care

COLOGNE, GERMANY - Media OutReach Newswire - 11 September 2025 - Momcozy, a global leader in maternal care and a pioneer of the Mom-First philosophy, announced at Kind+Jugend that its Ergonest M...

Australian representation at CIFTIS reflects deepening cooperation with China: experts

BEIJING, CHINA - Media OutReach Newswire - 11 September 2025 - The 2025 China International Fair for Trade in Services (CIFTIS) reflects the deepening cooperation between China and Australia in se...

Holding High the Banner of Opening-up and Leading Trade in Services, Beijing Is Setting a New Benchmark for Opening up the Chinese Services Sector: Through the Lens of CIFTIS

BEIJING, CHINA - Media OutReach Newswire - 11 September 2025 - On September 10, the 2025 China International Fair for Trade in Services (CIFTIS), themed "Embrace Intelligent Technologies, Empower ...

Chinese services trade fair draws global participation, highlights open markets

BEIJING, CHINA - Media OutReach Newswire - 11 September 2025 - Against the backdrop of repurposed blast furnaces and industrial relics of Shougang Park in western Beijing, the 2025 China Internati...

AWS research shows strong AI adoption momentum in Australia, with startups outpacing large enterprises in innovation

Amazon Web Services (AWS), an Amazon.com company, released new research revealing that while artificial intelligence (AI) adoption continues to acce...

Changing the World One Bite At a Time: IKU Turns 40

One of Australia’s first plant-based, chef-led eateries and now ready meal provider IKU is celebrating its 40 year anniversary with the business e...

Three generations marking 45 years in hot-air balloons

Australia’s leading hot-air balloon company is celebrating 45 years in the sky and its 700,000th passenger, driven by the passion of father-son du...

Workplace DMs, Reinvented: Deputy Messaging, Purpose-Built For Shift-Based Teams

Deputy, the global people platform for shift-based businesses, has launched Deputy Messaging, a fully integrated, real-time communication tool designe...

Revolutionizing Fulfillment: How Virtual Warehousing is Changing the Game?

The e-commerce landscape is evolving more rapidly than ever, and the way businesses are managing their fulfillment is also revolutionizing. At the...

SME lender Dynamoney welcomes new CEO, Brett Thomas

Strengthens growth ambitions and signals expanded offering Dynamoney, a leading commercial finance provider for Australian SMEs,  has today appoint...

Sell by LayBy